DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,504 filers reported holding DANAHER CORPORATION in Q4 2019. The put-call ratio across all filers is 1.66 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $980,000 | -1.0% | 6,384 | -6.8% | 0.13% | -7.8% |
| Q3 2019 | $990,000 | +19.4% | 6,852 | +18.1% | 0.14% | +21.6% |
| Q2 2019 | $829,000 | +9.4% | 5,800 | +1.0% | 0.12% | +8.4% |
| Q1 2019 | $758,000 | +25.5% | 5,743 | -1.8% | 0.11% | +9.2% |
| Q4 2018 | $604,000 | -1.6% | 5,847 | +3.5% | 0.10% | +16.7% |
| Q3 2018 | $614,000 | +10.0% | 5,648 | 0.0% | 0.08% | +9.1% |
| Q2 2018 | $558,000 | +0.9% | 5,648 | 0.0% | 0.08% | +1.3% |
| Q1 2018 | $553,000 | +5.5% | 5,648 | 0.0% | 0.08% | +15.2% |
| Q4 2017 | $524,000 | +10.3% | 5,648 | +2.1% | 0.07% | +6.5% |
| Q3 2017 | $475,000 | +1.1% | 5,534 | -0.5% | 0.06% | -1.6% |
| Q2 2017 | $470,000 | -12.6% | 5,564 | -11.4% | 0.06% | -14.9% |
| Q1 2017 | $538,000 | +8.7% | 6,282 | -1.2% | 0.07% | +2.8% |
| Q4 2016 | $495,000 | -0.2% | 6,361 | +0.6% | 0.07% | -4.0% |
| Q3 2016 | $496,000 | -35.5% | 6,321 | -16.9% | 0.08% | -37.0% |
| Q2 2016 | $769,000 | +14.4% | 7,611 | +7.5% | 0.12% | +0.8% |
| Q1 2016 | $672,000 | +2.0% | 7,079 | -0.3% | 0.12% | +1.7% |
| Q4 2015 | $659,000 | +9.1% | 7,097 | +0.1% | 0.12% | +5.5% |
| Q3 2015 | $604,000 | -12.7% | 7,088 | -12.3% | 0.11% | -4.3% |
| Q2 2015 | $692,000 | +0.7% | 8,084 | 0.0% | 0.12% | -5.0% |
| Q1 2015 | $687,000 | -15.0% | 8,084 | -14.3% | 0.12% | -14.8% |
| Q4 2014 | $808,000 | +12.7% | 9,434 | 0.0% | 0.14% | -0.7% |
| Q3 2014 | $717,000 | -3.5% | 9,434 | 0.0% | 0.14% | +2.1% |
| Q2 2014 | $743,000 | -3.3% | 9,434 | -7.9% | 0.14% | -11.9% |
| Q1 2014 | $768,000 | -1.7% | 10,241 | +1.2% | 0.16% | -8.6% |
| Q4 2013 | $781,000 | +11.4% | 10,116 | 0.0% | 0.17% | +1.8% |
| Q3 2013 | $701,000 | -71.6% | 10,116 | -74.1% | 0.17% | +17.9% |
| Q2 2013 | $2,471,000 | – | 39,055 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |